Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Gene Therapy: What You Need to Know (Warrior FAQs)
source: Sickle Cell Disease Association of America Inc.
year: 2023
summary/abstract:Two gene therapies were recently approved by the Food and Drug Administration (FDA) to treat sickle cell disease: Casegevy from CRISPR/Vertex and Lyfgenia from bluebird bio. You probably have questions about these new treatment options. Read more below.
Is gene therapy a cure for sickle cell disease?
Gene therapy is a potentially curative therapy. This means that it could act as a cure, but it is too new to say for sure. It causes a big decline in pain episodes, but we need to learn more about long-term impacts and side effects. It is also not a “one-and-done” treatment. The FDA currently recommends 15 years of patient follow up.
+myBinderRelated Content
-
Sickle Cell Disease Association-St. PetersburgAs a non-profit 501(c)3 organization, Si...
-
Prodigy’s death shines light on slow progress against sickle cell diseaseThe death of the rap artist Prodigy (Alb...
-
A CRISPR Focus on Attitudes and Beliefs Toward Somatic Genome Editing From Stakeholders Within the Sickle Cell Disea...Purpose: Genome editing holds both trem...
-
Isaac OkelloIsaac Okello is a Sickle Cell Advocate f...
-
Today’s Faces of Sickle Cell Disease: Pat Corley, RNIn 1979, while she was volunteering at a...
-
Community Health Workers as Support for Sickle Cell CareCommunity health workers are increasingl...
-
Lorri BurgessLorri Burgess was the Chief Operating Of...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.